alpha-Methylbenzeneethaneamine en es it fr

alpha-Methylbenzeneethaneamine Brand names, alpha-Methylbenzeneethaneamine Analogs

alpha-Methylbenzeneethaneamine Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

alpha-Methylbenzeneethaneamine Chemical_Formula

C9H13N

alpha-Methylbenzeneethaneamine RX_link

http://www.rxlist.com/cgi/generic3/adderallxr.htm

alpha-Methylbenzeneethaneamine fda sheet

alpha-Methylbenzeneethaneamine msds (material safety sheet)

alpha-Methylbenzeneethaneamine Synthesis Reference

U. S. Pat. 1,879,003, (1932)

alpha-Methylbenzeneethaneamine Molecular Weight

135.206 g/mol

alpha-Methylbenzeneethaneamine Melting Point

Volatizes slowly at room temperature

alpha-Methylbenzeneethaneamine H2O Solubility

Slightly

alpha-Methylbenzeneethaneamine State

Solid

alpha-Methylbenzeneethaneamine LogP

1.799

alpha-Methylbenzeneethaneamine Dosage Forms

Capsules

alpha-Methylbenzeneethaneamine Indication

For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

alpha-Methylbenzeneethaneamine Pharmacology

Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

alpha-Methylbenzeneethaneamine Absorption

It forms easily absorbed molecules that are highly lipid soluble

alpha-Methylbenzeneethaneamine side effects and Toxicity

LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

alpha-Methylbenzeneethaneamine Patient Information

Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

alpha-Methylbenzeneethaneamine Organisms Affected

Humans and other mammals